{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:41:37Z","timestamp":1793943697310,"version":"4.8.0"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41581-025-00970-1","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T08:48:59Z","timestamp":1750063739000},"page":"597-612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Nephrogenomics, precision medicine and the role of genetic testing in adult kidney disease management"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4788-7974","authenticated-orcid":false,"given":"Ilias","family":"Bensouna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Doreille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Dancer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7519-9822","authenticated-orcid":false,"given":"Anne-Sophie","family":"Lebre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0339-3757","authenticated-orcid":false,"given":"Laurent","family":"Mesnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"970_CR1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1806891","volume":"380","author":"EE Groopman","year":"2019","unstructured":"Groopman, E. E. et al. Diagnostic utility of exome sequencing for kidney disease. N. Engl. J. Med. 380, 142\u2013151 (2019).","journal-title":"N. Engl. J. Med."},{"key":"970_CR2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/ajmg.c.31995","volume":"190","author":"LR Claus","year":"2022","unstructured":"Claus, L. R., Snoek, R., Knoers, N. V. A. M. & van Eerde, A. M. Review of genetic testing in kidney disease patients: diagnostic yield of single nucleotide variants and copy number variations evaluated across and within kidney phenotype groups. Am. J. Med. Genet. Part C Semin. Med. Genet. 190, 358\u2013376 (2022).","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"970_CR3","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ekir.2022.12.007","volume":"8","author":"A Doreille","year":"2023","unstructured":"Doreille, A. et al. Exome-first strategy in adult patients with CKD: a cohort study. Kidney Int. Rep. 8, 596\u2013605 (2023).","journal-title":"Kidney Int. Rep."},{"key":"970_CR4","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/j.ekir.2023.07.003","volume":"8","author":"T Robert","year":"2023","unstructured":"Robert, T. et al. Diagnosis of kidney diseases of unknown etiology through biopsy-genetic analysis. Kidney Int. Rep. 8, 2077\u20132087 (2023).","journal-title":"Kidney Int. Rep."},{"key":"970_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfad099","volume":"17","author":"T Robert","year":"2024","unstructured":"Robert, T. et al. Beyond the kidney biopsy: genomic approach to undetermined kidney diseases. Clin. Kidney J. 17, sfad099 (2024).","journal-title":"Clin. Kidney J."},{"key":"970_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1056\/NEJMra2308577","volume":"391","author":"A Vivante","year":"2024","unstructured":"Vivante, A. Genetics of chronic kidney disease. N. Engl. J. Med. 391, 627\u2013639 (2024).","journal-title":"N. Engl. J. Med."},{"key":"970_CR7","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1038\/s41436-019-0477-2","volume":"21","author":"ED Smith","year":"2019","unstructured":"Smith, E. D. et al. A retrospective review of multiple findings in diagnostic exome sequencing: half are distinct and half are overlapping diagnoses. Genet. Med. 21, 2199\u20132207 (2019).","journal-title":"Genet. Med."},{"key":"970_CR8","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.kint.2022.03.019","volume":"101","author":"A K\u00f6ttgen","year":"2022","unstructured":"K\u00f6ttgen, A. et al. Genetics in chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 101, 1126\u20131141 (2022).","journal-title":"Kidney Int."},{"key":"970_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41436-020-00963-4","volume":"23","author":"K Jayasinghe","year":"2021","unstructured":"Jayasinghe, K. et al. Clinical impact of genomic testing in patients with suspected monogenic kidney disease. Genet. Med. 23, 183\u2013191 (2021).","journal-title":"Genet. Med."},{"key":"970_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/MNH.0000000000000836","volume":"31","author":"AJ Mallett","year":"2022","unstructured":"Mallett, A. J. Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future. Curr. Opin. Nephrol. Hypertens. 31, 541\u2013547 (2022).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"970_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1182\/blood.2022015583","volume":"141","author":"A Doreille","year":"2023","unstructured":"Doreille, A., Rafat, C., Rondeau, E. & Mesnard, L. How I treat thrombotic microangiopathy in the era of rapid genomics. Blood 141, 147\u2013155 (2023).","journal-title":"Blood"},{"key":"970_CR12","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1182\/blood.2024024976","volume":"144","author":"N Yousfi","year":"2024","unstructured":"Yousfi, N. et al. Genomic analysis of adult thrombotic microangiopathies in less than 3 days: from rapid to fast genomics to treatment. Blood J. 144, 2266\u20132269 (2024).","journal-title":"Blood J."},{"key":"970_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21790-4","volume":"12","author":"D Vitsios","year":"2021","unstructured":"Vitsios, D., Dhindsa, R. S., Middleton, L., Gussow, A. B. & Petrovski, S. Prioritizing non-coding regions based on human genomic constraint and sequence context with deep learning. Nat. Commun. 12, 1504 (2021).","journal-title":"Nat. Commun."},{"key":"970_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1681\/ASN.2019050515","volume":"31","author":"PF Zipfel","year":"2020","unstructured":"Zipfel, P. F., Wiech, T., Stea, E. D. & Skerka, C. CFHR gene variations provide insights in the pathogenesis of the kidney diseases atypical hemolytic uremic syndrome and C3 glomerulopathy. J. Am. Soc. Nephrol. 31, 241\u2013256 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"970_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41581-021-00424-4","volume":"17","author":"F Fakhouri","year":"2021","unstructured":"Fakhouri, F. & Fr\u00e9meaux-Bacchi, V. Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics. Nat. Rev. Nephrol. 17, 543\u2013553 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"970_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.kint.2024.05.015","volume":"106","author":"M Vivarelli","year":"2024","unstructured":"Vivarelli, M. et al. The role of complement in kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 106, 369\u2013391 (2024).","journal-title":"Kidney Int."},{"key":"970_CR17","doi-asserted-by":"publisher","first-page":"821189","DOI":"10.3389\/fneur.2022.821189","volume":"13","author":"L Marsili","year":"2022","unstructured":"Marsili, L., Duque, K. R., Bode, R. L., Kauffman, M. A. & Espay, A. J. Uncovering essential tremor genetics: the promise of long-read sequencing. Front. Neurol. 13, 821189 (2022).","journal-title":"Front. Neurol."},{"key":"970_CR18","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41576-024-00692-3","volume":"25","author":"HA Tanudisastro","year":"2024","unstructured":"Tanudisastro, H. A., Deveson, I. W., Dashnow, H. & MacArthur, D. G. Sequencing and characterizing short tandem repeats in the human genome. Nat. Rev. Genet. 25, 460\u2013475 (2024).","journal-title":"Nat. Rev. Genet."},{"key":"970_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1053\/j.ajkd.2018.03.019","volume":"72","author":"N Ayasreh","year":"2018","unstructured":"Ayasreh, N. et al. Autosomal dominant tubulointerstitial kidney disease: clinical presentation of patients with ADTKD-UMOD and ADTKD-MUC1. Am. J. Kidney Dis. 72, 411\u2013418 (2018).","journal-title":"Am. J. Kidney Dis."},{"key":"970_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/ng.2543","volume":"45","author":"A Kirby","year":"2013","unstructured":"Kirby, A. et al. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat. Genet. 45, 299\u2013303 (2013).","journal-title":"Nat. Genet."},{"key":"970_CR21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/ki.2014.72","volume":"86","author":"AB Ekici","year":"2014","unstructured":"Ekici, A. B. et al. Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in Mucin 1 or uromodulin. Kidney Int. 86, 589\u2013599 (2014).","journal-title":"Kidney Int."},{"key":"970_CR22","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jmoldx.2016.03.003","volume":"18","author":"B Blumenstiel","year":"2016","unstructured":"Blumenstiel, B. et al. Development and validation of a mass spectrometry-based assay for the molecular diagnosis of Mucin-1 kidney disease. J. Mol. Diagn. 18, 566\u2013571 (2016).","journal-title":"J. Mol. Diagn."},{"key":"970_CR23","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/ndt\/gfx083","volume":"32","author":"S Yamamoto","year":"2017","unstructured":"Yamamoto, S. et al. Analysis of an ADTKD family with a novel frameshift mutation in MUC1 reveals characteristic features of mutant MUC1 protein. Nephrol. Dial. Transpl. 32, 2010\u20132017 (2017).","journal-title":"Nephrol. Dial. Transpl."},{"key":"970_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107171","volume":"26","author":"H Saei","year":"2023","unstructured":"Saei, H. et al. VNtyper enables accurate alignment-free genotyping of MUC1 coding VNTR using short-read sequencing data in autosomal dominant tubulointerstitial kidney disease. iScience 26, 107171 (2023).","journal-title":"iScience"},{"key":"970_CR25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1681\/ASN.0000000503","volume":"36","author":"I Bensouna","year":"2024","unstructured":"Bensouna, I. et al. Systematic screening of autosomal dominant tubulointerstitial kidney disease\u2013MUC1 27dupC pathogenic variant through exome sequencing. J. Am. Soc. Nephrol. 36, 256\u2013263 (2024).","journal-title":"J. Am. Soc. Nephrol."},{"key":"970_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.abj6987","volume":"376","author":"S Nurk","year":"2022","unstructured":"Nurk, S. et al. The complete sequence of a human genome. Science 376, 44\u201353 (2022).","journal-title":"Science"},{"key":"970_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41586-023-05896-x","volume":"617","author":"W-W Liao","year":"2023","unstructured":"Liao, W.-W. et al. A draft human pangenome reference. Nature 617, 312\u2013324 (2023).","journal-title":"Nature"},{"key":"970_CR28","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ekir.2021.12.037","volume":"7","author":"E Okada","year":"2022","unstructured":"Okada, E. et al. Detecting MUC1 variants in patients clinicopathologically diagnosed with having autosomal dominant tubulointerstitial kidney disease. Kidney Int. Rep. 7, 857\u2013866 (2022).","journal-title":"Kidney Int. Rep."},{"key":"970_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40761-w","volume":"9","author":"H Ali","year":"2019","unstructured":"Ali, H. et al. PKD1 duplicated regions limit clinical utility of whole exome sequencing for genetic diagnosis of autosomal dominant polycystic kidney disease. Sci. Rep. 9, 4141 (2019).","journal-title":"Sci. Rep."},{"key":"970_CR30","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/s41592-023-01993-x","volume":"20","author":"M Kolmogorov","year":"2023","unstructured":"Kolmogorov, M. et al. Scalable nanopore sequencing of human genomes provides a comprehensive view of haplotype-resolved variation and methylation. Nat. Methods 20, 1483\u20131492 (2023).","journal-title":"Nat. Methods"},{"key":"970_CR31","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s41588-019-0528-2","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin, A. R. et al. PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels. Nat. Genet. 51, 1560\u20131565 (2019).","journal-title":"Nat. Genet."},{"key":"970_CR32","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.ajhg.2021.06.020","volume":"108","author":"Z Stark","year":"2021","unstructured":"Stark, Z. et al. Scaling national and international improvement in virtual gene panel curation via a collaborative approach to discordance resolution. Am. J. Hum. Genet. 108, 1551\u20131557 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"970_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41581-024-00900-7","volume":"21","author":"Z Stark","year":"2025","unstructured":"Stark, Z., Byrne, A. B., Sampson, M. G., Lennon, R. & Mallett, A. J. A guide to gene\u2013disease relationships in nephrology. Nat. Rev. Nephrol. 21, 115\u2013126 (2025).","journal-title":"Nat. Rev. Nephrol."},{"key":"970_CR34","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/humu.22858","volume":"36","author":"AA Philippakis","year":"2015","unstructured":"Philippakis, A. A. et al. The matchmaker exchange: a platform for rare disease gene discovery. Hum. Mutat. 36, 915\u2013921 (2015).","journal-title":"Hum. Mutat."},{"key":"970_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.kint.2024.02.021","volume":"106","author":"BM Ma","year":"2024","unstructured":"Ma, B. M. et al. Developing a genetic testing panel for evaluation of morbidities in kidney transplant recipients. Kidney Int. 106, 115\u2013125 (2024).","journal-title":"Kidney Int."},{"key":"970_CR36","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1053\/j.ajkd.2024.04.021","volume":"84","author":"M Blasco","year":"2024","unstructured":"Blasco, M. et al. Genetic characterization of kidney failure of unknown etiology in Spain: findings from the GENSEN study. Am. J. Kidney Dis. 84, 719\u2013730.e1 (2024).","journal-title":"Am. J. Kidney Dis."},{"key":"970_CR37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI178573","volume":"134","author":"MD Elliott","year":"2024","unstructured":"Elliott, M. D. et al. Increased risk of kidney failure in patients with genetic kidney disorders. J. Clin. Invest. 134, e178573 (2024).","journal-title":"J. Clin. Invest."},{"key":"970_CR38","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"970_CR39","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/humu.23626","volume":"39","author":"AN Abou Tayoun","year":"2018","unstructured":"Abou Tayoun, A. N. et al. Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion. Hum. Mutat. 39, 1517\u20131524 (2018).","journal-title":"Hum. Mutat."},{"key":"970_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0690-2","volume":"12","author":"SE Brnich","year":"2019","unstructured":"Brnich, S. E. et al. Recommendations for application of the functional evidence PS3\/BS3 criterion using the ACMG\/AMP sequence variant interpretation framework. Genome Med. 12, 3 (2019).","journal-title":"Genome Med."},{"key":"970_CR41","doi-asserted-by":"publisher","first-page":"101036","DOI":"10.1016\/j.gim.2023.101036","volume":"26","author":"RJ Schmidt","year":"2024","unstructured":"Schmidt, R. J. et al. Recommendations for risk allele evidence curation, classification, and reporting from the ClinGen low penetrance\/risk allele working group. Genet. Med. 26, 101036 (2024).","journal-title":"Genet. Med."},{"key":"970_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/ndt\/gfab218","volume":"37","author":"N Knoers","year":"2021","unstructured":"Knoers, N. et al. Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice. Nephrol. Dial. Transpl. 37, 239\u2013254 (2021).","journal-title":"Nephrol. Dial. Transpl."},{"key":"970_CR43","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/s41431-022-01091-0","volume":"30","author":"ZC Deans","year":"2022","unstructured":"Deans, Z. C. et al. Recommendations for reporting results of diagnostic genomic testing. Eur. J. Hum. Genet. 30, 1011\u20131016 (2022).","journal-title":"Eur. J. Hum. Genet."},{"key":"970_CR44","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41431-021-00858-1","volume":"29","author":"J Savige","year":"2021","unstructured":"Savige, J. et al. Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria. Eur. J. Hum. Genet. 29, 1186\u20131197 (2021).","journal-title":"Eur. J. Hum. Genet."},{"key":"970_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ejhg.2015.226","volume":"24","author":"G Matthijs","year":"2016","unstructured":"Matthijs, G. et al. Guidelines for diagnostic next-generation sequencing. Eur. J. Hum. Genet. 24, 2\u20135 (2016).","journal-title":"Eur. J. Hum. Genet."},{"key":"970_CR46","doi-asserted-by":"publisher","first-page":"100866","DOI":"10.1016\/j.gim.2023.100866","volume":"25","author":"DT Miller","year":"2023","unstructured":"Miller, D. T. et al. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 25, 100866 (2023).","journal-title":"Genet. Med."},{"key":"970_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ajhg.2016.06.001","volume":"99","author":"LM Amendola","year":"2016","unstructured":"Amendola, L. M. et al. Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the clinical sequencing exploratory research consortium. Am. J. Hum. Genet. 99, 247 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"970_CR48","first-page":"8.16.1","volume":"89","author":"SM Harrison","year":"2016","unstructured":"Harrison, S. M. et al. Using ClinVar as a resource to support variant interpretation. Curr. Protoc. Hum. Genet. 89, 8.16.1\u20138.16.23 (2016).","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"970_CR49","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.ajhg.2022.10.006","volume":"109","author":"E Tudini","year":"2022","unstructured":"Tudini, E. et al. Shariant platform: enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretation. Am. J. Hum. Genet. 109, 1960\u20131973 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"970_CR50","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/humu.22965","volume":"37","author":"D Salgado","year":"2016","unstructured":"Salgado, D. et al. UMD-predictor: a high-throughput sequencing compliant system for pathogenicity prediction of any human cDNA substitution. Hum. Mutat. 37, 439\u2013446 (2016).","journal-title":"Hum. Mutat."},{"key":"970_CR51","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1093\/nar\/gkg509","volume":"31","author":"PC Ng","year":"2003","unstructured":"Ng, P. C. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 31, 3812\u20133814 (2003).","journal-title":"Nucleic Acids Res."},{"key":"970_CR52","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248\u2013249 (2010).","journal-title":"Nat. Methods"},{"key":"970_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31686-6","volume":"13","author":"L Gerasimavicius","year":"2022","unstructured":"Gerasimavicius, L., Livesey, B. J. & Marsh, J. A. Loss-of-function, gain-of-function and dominant-negative mutations have profoundly different effects on protein structure. Nat. Commun. 13, 3895 (2022).","journal-title":"Nat. Commun."},{"key":"970_CR54","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.kint.2020.06.026","volume":"98","author":"M Noris","year":"2020","unstructured":"Noris, M. & Remuzzi, G. Atypical hemolytic uremic syndrome associated with a factor B genetic variant and fluid-phase complement activation: an exception to the rule? Kidney Int. 98, 1084\u20131087 (2020).","journal-title":"Kidney Int."},{"key":"970_CR55","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1681\/ASN.2013121339","volume":"26","author":"E Valoti","year":"2015","unstructured":"Valoti, E. et al. A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1\/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation. J. Am. Soc. Nephrol. 26, 209\u2013219 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"970_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1206","volume":"8","author":"M Vihinen","year":"2020","unstructured":"Vihinen, M. Problems in variation interpretation guidelines and in their implementation in computational tools. Mol. Genet. Genom. Med. 8, e1206 (2020).","journal-title":"Mol. Genet. Genom. Med."},{"key":"970_CR57","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/ckj\/sfac041","volume":"15","author":"A Doreille","year":"2022","unstructured":"Doreille, A., Villi\u00e9, P. & Mesnard, L. National survey on genetic test prescription in French adult nephrologists: a call for simplification and education. Clin. Kidney J. 15, 1213\u20131215 (2022).","journal-title":"Clin. Kidney J."},{"key":"970_CR58","doi-asserted-by":"publisher","first-page":"100814","DOI":"10.1016\/j.gim.2023.100814","volume":"25","author":"HM Rasouly","year":"2023","unstructured":"Rasouly, H. M. et al. The impact of genetic education on referral of patients to genetic evaluation: findings from a national survey of nephrologists. Genet. Med. 25, 100814 (2023).","journal-title":"Genet. Med."},{"key":"970_CR59","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/s41436-021-01140-x","volume":"23","author":"A Nisselle","year":"2021","unstructured":"Nisselle, A. et al. Ensuring best practice in genomics education and evaluation: reporting item standards for education and its evaluation in genomics (RISE2 Genomics). Genet. Med. 23, 1356\u20131365 (2021).","journal-title":"Genet. Med."},{"key":"970_CR60","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fgene.2020.00151","volume":"11","author":"BJ McClaren","year":"2020","unstructured":"McClaren, B. J. et al. Preparing medical specialists for genomic medicine: continuing education should include opportunities for experiential learning. Front. Genet. 11, 151 (2020).","journal-title":"Front. Genet."},{"key":"970_CR61","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.ekir.2024.04.068","volume":"9","author":"K Jayasinghe","year":"2024","unstructured":"Jayasinghe, K. et al. Implementation and evaluation of a national multidisciplinary kidney genetics clinic network over ten years. Kidney Int. Rep. 9, 2372\u20132385 (2024).","journal-title":"Kidney Int. Rep."},{"key":"970_CR62","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s41436-021-01100-5","volume":"23","author":"RL Haspel","year":"2021","unstructured":"Haspel, R. L. et al. Call for improvement in medical school training in genetics: results of a national survey. Genet. Med. 23, 1151\u20131157 (2021).","journal-title":"Genet. Med."},{"key":"970_CR63","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2215\/CJN.08461109","volume":"5","author":"JS Berns","year":"2010","unstructured":"Berns, J. S. A survey-based evaluation of self-perceived competency after nephrology fellowship training. Clin. J. Am. Soc. Nephrol. 5, 490\u2013496 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"970_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.fhj.2024.100133","volume":"11","author":"L Seed","year":"2024","unstructured":"Seed, L. et al. Preparing tomorrow\u2019s doctors for the genomics era: a nationwide survey of UK medical students. Future Healthc. J. 11, 100133 (2024).","journal-title":"Future Healthc. J."},{"key":"970_CR65","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/imj.16369","volume":"54","author":"AJ Mallett","year":"2024","unstructured":"Mallett, A. J., Ingles, J., Goranitis, I. & Stark, Z. Implementation of reimbursement for genomic testing in Australia: early successes and the pathway ahead. Intern. Med. J. 54, 531\u2013534 (2024).","journal-title":"Intern. Med. J."},{"key":"970_CR66","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1001\/jama.2020.21506","volume":"324","author":"A Doreille","year":"2020","unstructured":"Doreille, A., Raymond, L. & Mesnard, L. Exome sequencing as part of a multidisciplinary approach to diagnosis. JAMA 324, 2445 (2020).","journal-title":"JAMA"},{"key":"970_CR67","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1001\/jama.2020.11126","volume":"324","author":"JM Friedman","year":"2020","unstructured":"Friedman, J. M., Jones, K. L. & Carey, J. C. Exome sequencing and clinical diagnosis. JAMA 324, 627\u2013628 (2020).","journal-title":"JAMA"},{"key":"970_CR68","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41525-018-0053-8","volume":"3","author":"MM Clark","year":"2018","unstructured":"Clark, M. M. et al. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. NPJ Genom. Med. 3, 16 (2018).","journal-title":"NPJ Genom. Med."},{"key":"970_CR69","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/gim.2016.224","volume":"19","author":"D Baldridge","year":"2017","unstructured":"Baldridge, D. et al. The exome clinic and the role of medical genetics expertise in the interpretation of exome sequencing results. Genet. Med. 19, 1040\u20131048 (2017).","journal-title":"Genet. Med."},{"key":"970_CR70","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/s41436-018-0343-7","volume":"21","author":"L Basel-Salmon","year":"2019","unstructured":"Basel-Salmon, L. et al. Improved diagnostics by exome sequencing following raw data reevaluation by clinical geneticists involved in the medical care of the individuals tested. Genet. Med. 21, 1443\u20131451 (2019).","journal-title":"Genet. Med."},{"key":"970_CR71","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41431-024-01555-5","volume":"32","author":"A Ma","year":"2024","unstructured":"Ma, A. et al. What is the power of a genomic multidisciplinary team approach? A systematic review of implementation and sustainability. Eur. J. Hum. Genet. 32, 381\u2013391 (2024).","journal-title":"Eur. J. Hum. Genet."},{"key":"970_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2023.104844","volume":"66","author":"KEM Diderich","year":"2023","unstructured":"Diderich, K. E. M. et al. The role of a multidisciplinary team in managing variants of uncertain clinical significance in prenatal genetic diagnosis. Eur. J. Med. Genet. 66, 104844 (2023).","journal-title":"Eur. J. Med. Genet."},{"key":"970_CR73","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.mayocp.2015.12.018","volume":"91","author":"KN Lazaridis","year":"2016","unstructured":"Lazaridis, K. N. et al. Outcome of whole exome sequencing for diagnostic odyssey cases of an individualized medicine clinic: the Mayo Clinic experience. Mayo Clin. Proc. 91, 297\u2013307 (2016).","journal-title":"Mayo Clin. Proc."},{"key":"970_CR74","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1002\/ajmg.a.62338","volume":"185","author":"NM Marinakis","year":"2021","unstructured":"Marinakis, N. M. et al. Phenotype-driven variant filtration strategy in exome sequencing toward a high diagnostic yield and identification of 85 novel variants in 400 patients with rare Mendelian disorders. Am. J. Med. Genet. A 185, 2561\u20132571 (2021).","journal-title":"Am. J. Med. Genet. A"},{"key":"970_CR75","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.3390\/jcm11144238","volume":"11","author":"L Vadlamudi","year":"2022","unstructured":"Vadlamudi, L. et al. A multi-disciplinary team approach to genomic testing for drug-resistant epilepsy patients-the GENIE study. J. Clin. Med. 11, 4238 (2022).","journal-title":"J. Clin. Med."},{"key":"970_CR76","unstructured":"LOI N\u00b0 2021-1017 Du 2 Ao\u00fbt 2021 Relative \u00e0 La Bio\u00e9thique (1). 2021-1017 (2021); https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000043884384."},{"key":"970_CR77","first-page":"427","volume":"206","author":"C Bergoignan Esper","year":"2022","unstructured":"Bergoignan Esper, C. M\u00e9decine g\u00e9nomique et loi du 2 ao\u00fbt 2021 relative \u00e0 la bio\u00e9thique: une circulation renforc\u00e9e des donn\u00e9es g\u00e9n\u00e9tiques sur la personne. Bull. Acad Natl M\u00e9d 206, 427\u2013432 (2022).","journal-title":"Bull. Acad Natl M\u00e9d"},{"key":"970_CR78","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/gim.2013.73","volume":"15","author":"RC Green","year":"2013","unstructured":"Green, R. C. et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. 15, 565\u2013574 (2013).","journal-title":"Genet. Med."},{"key":"970_CR79","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41436-018-0019-3","volume":"21","author":"LG Biesecker","year":"2019","unstructured":"Biesecker, L. G. Secondary findings in exome slices, virtual panels, and anticipatory sequencing. Genet. Med. 21, 41\u201343 (2019).","journal-title":"Genet. Med."},{"key":"970_CR80","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/jmedgenet-2015-103144","volume":"52","author":"K Boycott","year":"2015","unstructured":"Boycott, K. et al. The clinical application of genome-wide sequencing for monogenic diseases in Canada: position statement of the Canadian College of Medical Geneticists. J. Med. Genet. 52, 431\u2013437 (2015).","journal-title":"J. Med. Genet."},{"key":"970_CR81","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/538161a","volume":"538","author":"AB Popejoy","year":"2016","unstructured":"Popejoy, A. B. & Fullerton, S. M. Genomics is failing on diversity. Nature 538, 161\u2013164 (2016).","journal-title":"Nature"},{"key":"970_CR82","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2217\/pme.12.100","volume":"9","author":"E Ramos","year":"2012","unstructured":"Ramos, E., Callier, S. L. & Rotimi, C. N. Why personalized medicine will fail if we stay the course. Per Med. 9, 839\u2013847 (2012).","journal-title":"Per Med."},{"key":"970_CR83","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/475163a","volume":"475","author":"CD Bustamante","year":"2011","unstructured":"Bustamante, C. D., Burchard, E. G. & De la Vega, F. M. Genomics for the world. Nature 475, 163\u2013165 (2011).","journal-title":"Nature"},{"key":"970_CR84","doi-asserted-by":"publisher","first-page":"11983","DOI":"10.1073\/pnas.1019276108","volume":"108","author":"S Gravel","year":"2011","unstructured":"Gravel, S. et al. Demographic history and rare allele sharing among human populations. Proc. Natl Acad. Sci. USA 108, 11983\u201311988 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"970_CR85","doi-asserted-by":"publisher","first-page":"eade9214","DOI":"10.1126\/scitranslmed.ade9214","volume":"15","author":"GS Ginsburg","year":"2023","unstructured":"Ginsburg, G. S., Denny, J. C. & Schully, S. D. Data-driven science and diversity in the All of Us Research Program. Sci. Transl. Med. 15, eade9214 (2023).","journal-title":"Sci. Transl. Med."},{"key":"970_CR86","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41586-023-06957-x","volume":"627","author":"AG Bick","year":"2024","unstructured":"Bick, A. G. et al. Genomic data in the All of Us Research Program. Nature 627, 340\u2013346 (2024).","journal-title":"Nature"},{"key":"970_CR87","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","volume":"625","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature 625, 92\u2013100 (2024).","journal-title":"Nature"},{"key":"970_CR88","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/gim.2017.26","volume":"19","author":"N Whiffin","year":"2017","unstructured":"Whiffin, N. et al. Using high-resolution variant frequencies to empower clinical genome interpretation. Genet. Med. 19, 1151\u20131158 (2017).","journal-title":"Genet. Med."},{"key":"970_CR89","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.1251546","volume":"344","author":"H3Africa Consortium","year":"2014","unstructured":"H3Africa Consortium et al. Research capacity. Enabling the genomic revolution in Africa. Science 344, 1346\u20131348 (2014).","journal-title":"Science"},{"key":"970_CR90","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/genetics\/161.1.269","volume":"161","author":"N Yu","year":"2002","unstructured":"Yu, N. et al. Larger genetic differences within Africans than between Africans and Eurasians. Genetics 161, 269\u2013274 (2002).","journal-title":"Genetics"},{"key":"970_CR91","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41588-018-0273-y","volume":"51","author":"RM Sherman","year":"2019","unstructured":"Sherman, R. M. et al. Assembly of a pan-genome from deep sequencing of 910 humans of African descent. Nat. Genet. 51, 30\u201335 (2019).","journal-title":"Nat. Genet."},{"key":"970_CR92","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41576-020-0210-7","volume":"21","author":"RM Sherman","year":"2020","unstructured":"Sherman, R. M. & Salzberg, S. L. Pan-genomics in the human genome era. Nat. Rev. Genet. 21, 243\u2013254 (2020).","journal-title":"Nat. Rev. Genet."},{"key":"970_CR93","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","volume":"329","author":"G Genovese","year":"2010","unstructured":"Genovese, G. et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841\u2013845 (2010).","journal-title":"Science"},{"key":"970_CR94","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","volume":"369","author":"A Parsa","year":"2013","unstructured":"Parsa, A. et al. APOL1 risk variants, race, and progression of chronic kidney disease. N. Engl. J. Med. 369, 2183\u20132196 (2013).","journal-title":"N. Engl. J. Med."},{"key":"970_CR95","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2215\/CJN.15161219","volume":"16","author":"DJ Friedman","year":"2021","unstructured":"Friedman, D. J. & Pollak, M. R. APOL1 nephropathy: from genetics to clinical applications. Clin. J. Am. Soc. Nephrol. 16, 294\u2013303 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"970_CR96","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/humu.22080","volume":"33","author":"PN Robinson","year":"2012","unstructured":"Robinson, P. N. Deep phenotyping for precision medicine. Hum. Mutat. 33, 777\u2013780 (2012).","journal-title":"Hum. Mutat."},{"key":"970_CR97","doi-asserted-by":"publisher","first-page":"D1207","DOI":"10.1093\/nar\/gkaa1043","volume":"49","author":"S K\u00f6hler","year":"2021","unstructured":"K\u00f6hler, S. et al. The human phenotype ontology in 2021. Nucleic Acids Res. 49, D1207\u2013D1217 (2021).","journal-title":"Nucleic Acids Res."},{"key":"970_CR98","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1086\/514346","volume":"80","author":"VA McKusick","year":"2007","unstructured":"McKusick, V. A. Mendelian inheritance in man and its online version, OMIM. Am. J. Hum. Genet. 80, 588\u2013604 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"970_CR99","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","volume":"28","author":"S Nguengang Wakap","year":"2020","unstructured":"Nguengang Wakap, S. et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur. J. Hum. Genet. 28, 165\u2013173 (2020).","journal-title":"Eur. J. Hum. Genet."},{"key":"970_CR100","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ekir.2020.10.009","volume":"6","author":"LMP Palma","year":"2021","unstructured":"Palma, L. M. P., Sridharan, M. & Sethi, S. Complement in secondary thrombotic microangiopathy. Kidney Int. Rep. 6, 11\u201323 (2021).","journal-title":"Kidney Int. Rep."},{"key":"970_CR101","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00439-013-1331-2","volume":"132","author":"DN Cooper","year":"2013","unstructured":"Cooper, D. N., Krawczak, M., Polychronakos, C., Tyler-Smith, C. & Kehrer-Sawatzki, H. Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum. Genet. 132, 1077\u20131130 (2013).","journal-title":"Hum. Genet."},{"key":"970_CR102","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1159\/000538173","volume":"55","author":"J Serre","year":"2024","unstructured":"Serre, J. et al. Diagnostic yield of exome sequencing in early-onset hypertensive nephropathy in adults. Am. J. Nephrol. 55, 468\u2013471 (2024).","journal-title":"Am. J. Nephrol."},{"key":"970_CR103","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2215\/CJN.06060519","volume":"15","author":"S Landini","year":"2020","unstructured":"Landini, S. et al. Reverse phenotyping after whole-exome sequencing in steroid-resistant nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 15, 89\u2013100 (2020).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"970_CR104","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/humu.22020","volume":"33","author":"M Bower","year":"2012","unstructured":"Bower, M. et al. Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database. Hum. Mutat. 33, 457\u2013466 (2012).","journal-title":"Hum. Mutat."},{"key":"970_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43020-9","volume":"14","author":"Y Gupta","year":"2023","unstructured":"Gupta, Y. et al. Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease. Nat. Commun. 14, 7836 (2023).","journal-title":"Nat. Commun."},{"key":"970_CR106","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ajhg.2021.11.016","volume":"109","author":"SR Senum","year":"2021","unstructured":"Senum, S. R. et al. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype. Am. J. Hum. Genet. 109, 136\u2013156 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"970_CR107","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/s41587-022-01221-5","volume":"40","author":"SD Goenka","year":"2022","unstructured":"Goenka, S. D. et al. Accelerated identification of disease-causing variants with ultra-rapid nanopore genome sequencing. Nat. Biotechnol. 40, 1035\u20131041 (2022).","journal-title":"Nat. Biotechnol."},{"key":"970_CR108","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41525-024-00404-0","volume":"9","author":"SF Kingsmore","year":"2024","unstructured":"Kingsmore, S. F., Nofsinger, R. & Ellsworth, K. Rapid genomic sequencing for genetic disease diagnosis and therapy in intensive care units: a review. NPJ Genom. Med. 9, 17 (2024).","journal-title":"NPJ Genom. Med."},{"key":"970_CR109","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1681\/ASN.0000000000000076","volume":"34","author":"F Becherucci","year":"2023","unstructured":"Becherucci, F. et al. A clinical workflow for cost-saving high-rate diagnosis of genetic kidney diseases. J. Am. Soc. Nephrol. 34, 706\u2013720 (2023).","journal-title":"J. Am. Soc. Nephrol."},{"key":"970_CR110","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.gim.2022.01.013","volume":"24","author":"I Goranitis","year":"2022","unstructured":"Goranitis, I. et al. Is faster better? An economic evaluation of rapid and ultra-rapid genomic testing in critically ill infants and children. Genet. Med. 24, 1037\u20131044 (2022).","journal-title":"Genet. Med."},{"key":"970_CR111","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ajhg.2019.08.009","volume":"105","author":"SF Kingsmore","year":"2019","unstructured":"Kingsmore, S. F. et al. A randomized, controlled trial of the analytic and diagnostic performance of singleton and trio, rapid genome and exome sequencing in ill infants. Am. J. Hum. Genet. 105, 719\u2013733 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"970_CR112","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1001\/jamapediatrics.2021.3496","volume":"175","author":"NICUSeq Study Group.","year":"2021","unstructured":"NICUSeq Study Group. et al. Effect of whole-genome sequencing on the clinical management of acutely ill infants with suspected genetic disease: a randomized clinical trial. JAMA Pediatr. 175, 1218\u20131226 (2021).","journal-title":"JAMA Pediatr."},{"key":"970_CR113","unstructured":"National Human Genome Research Institute. The cost of sequencing a human genome. https:\/\/www.genome.gov\/about-genomics\/fact-sheets\/Sequencing-Human-Genome-cost (2021)."},{"key":"970_CR114","unstructured":"Prevention Genetics. Nephrology genetic tests. https:\/\/www.preventiongenetics.com\/ClinicalTesting\/categories\/nephrology."},{"key":"970_CR115","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/ckj\/sfx102","volume":"11","author":"AA Al Turk","year":"2018","unstructured":"Al Turk, A. A., Estiverne, C., Agrawal, P. R. & Michaud, J. M. Trends and outcomes of the use of percutaneous native kidney biopsy in the United States: 5-year data analysis of the nationwide inpatient sample. Clin. Kidney J. 11, 330\u2013336 (2018).","journal-title":"Clin. Kidney J."},{"key":"970_CR116","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.2215\/CJN.14721219","volume":"15","author":"J-M Halimi","year":"2020","unstructured":"Halimi, J.-M. et al. Major bleeding and risk of death after percutaneous native kidney biopsies: a French nationwide cohort study. Clin. J. Am. Soc. Nephrol. 15, 1587\u20131594 (2020).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"970_CR117","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1007\/s12325-023-02608-9","volume":"40","author":"V Jha","year":"2023","unstructured":"Jha, V. et al. Global economic burden associated with chronic kidney disease: a pragmatic review of medical costs for the inside CKD research programme. Adv. Ther. 40, 4405\u20134420 (2023).","journal-title":"Adv. Ther."},{"key":"970_CR118","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1016\/j.ekir.2021.08.028","volume":"6","author":"K Jayasinghe","year":"2021","unstructured":"Jayasinghe, K. et al. Cost-effectiveness of targeted exome analysis as a diagnostic test in glomerular diseases. Kidney Int. Rep. 6, 2850\u20132861 (2021).","journal-title":"Kidney Int. Rep."},{"key":"970_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2023.100942","volume":"25","author":"Y Wu","year":"2023","unstructured":"Wu, Y. et al. Genomic testing for suspected monogenic kidney disease in children and adults: a health economic evaluation. Genet. Med. 25, 100942 (2023).","journal-title":"Genet. Med."},{"key":"970_CR120","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1681\/ASN.2017111200","volume":"29","author":"R Snoek","year":"2018","unstructured":"Snoek, R. et al. (Nephrocystin-1) gene deletions cause adult-onset ESRD. J. Am. Soc. Nephrol. 29, 1772\u20131779 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"970_CR121","doi-asserted-by":"publisher","first-page":"772","DOI":"10.34067\/KID.0001342020","volume":"1","author":"PC Wilson","year":"2020","unstructured":"Wilson, P. C. et al. Beyond panel-based testing: exome analysis increases sensitivity for diagnosis of genetic kidney disease. Kidney360 1, 772\u2013780 (2020).","journal-title":"Kidney360"},{"key":"970_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2022.09.017","volume":"25","author":"G Raca","year":"2023","unstructured":"Raca, G. et al. Points to consider in the detection of germline structural variants using next-generation sequencing: a statement of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 25, 100316 (2023).","journal-title":"Genet. Med."},{"key":"970_CR123","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrneph.2015.214","volume":"12","author":"F Emma","year":"2016","unstructured":"Emma, F., Montini, G., Parikh, S. M. & Salviati, L. Mitochondrial dysfunction in inherited renal disease and acute kidney injury. Nat. Rev. Nephrol. 12, 267\u2013280 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"970_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nefro.2023.03.004","volume":"43","author":"F Ferreira","year":"2023","unstructured":"Ferreira, F. et al. Renal manifestations in adults with mitochondrial disease from the mtDNA m.3243A>G pathogenic variant. Nefrologia 43, 1\u20137 (2023).","journal-title":"Nefrologia"},{"key":"970_CR125","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/imr.13131","volume":"313","author":"S Rodr\u00edguez De C\u00f3rdoba","year":"2023","unstructured":"Rodr\u00edguez De C\u00f3rdoba, S. Genetic variability shapes the alternative pathway complement activity and predisposition to complement\u2010related diseases. Immunol. Rev. 313, 71\u201390 (2023).","journal-title":"Immunol. Rev."},{"key":"970_CR126","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41431-023-01350-8","volume":"31","author":"A Hamza","year":"2023","unstructured":"Hamza, A. et al. The absence of CFHR3 and CFHR1 genes from the T2T-CHM13 assembly can limit the molecular diagnosis of complement-related diseases. Eur. J. Hum. Genet. 31, 730\u2013732 (2023).","journal-title":"Eur. J. Hum. Genet."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00970-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00970-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00970-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T22:24:13Z","timestamp":1757197453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00970-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":126,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["970"],"URL":"https:\/\/doi.org\/10.1038\/s41581-025-00970-1","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"19 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.D. is employed by Eurofins Biomnis. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}